Similarly, IL-6 is elevated in both colorectal and pancreatic cancer (PC) patients and promotes proliferation and anti-apoptotic effects in CRC; further, IL-6 is correlated with advanced stages and poor survival of PC patients [51,52]. This evidence concerns the gene IL6 and pachyonychia congenita.